These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 15001987)

  • 1. Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
    Héroult M; Bernard-Pierrot I; Delbé J; Hamma-Kourbali Y; Katsoris P; Barritault D; Papadimitriou E; Plouet J; Courty J
    Oncogene; 2004 Mar; 23(9):1745-53. PubMed ID: 15001987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of heparin affin regulatory peptide on the expression of vascular endothelial growth factor receptors in endothelial cells.
    Kokolakis G; Mikelis C; Papadimitriou E; Courty J; Karetsou E; Katsoris P
    In Vivo; 2006; 20(5):629-35. PubMed ID: 17091770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin affin regulatory peptide/pleiotrophin negatively affects diverse biological activities in C6 glioma cells.
    Parthymou A; Lampropoulou E; Mikelis C; Drosou G; Papadimitriou E
    Eur J Cell Biol; 2008 Jan; 87(1):17-29. PubMed ID: 17881084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of heparin affin regulatory peptide domains with potential role on angiogenesis.
    Polykratis A; Delbé J; Courty J; Papadimitriou E; Katsoris P
    Int J Biochem Cell Biol; 2004 Oct; 36(10):1954-66. PubMed ID: 15203110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenic response of endothelial cells to heparin-binding domain of fibronectin.
    Viji RI; Kumar VB; Kiran MS; Sudhakaran PR
    Int J Biochem Cell Biol; 2008; 40(2):215-26. PubMed ID: 17766169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
    Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine lactoferricin inhibits basic fibroblast growth factor- and vascular endothelial growth factor165-induced angiogenesis by competing for heparin-like binding sites on endothelial cells.
    Mader JS; Smyth D; Marshall J; Hoskin DW
    Am J Pathol; 2006 Nov; 169(5):1753-66. PubMed ID: 17071598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
    Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T
    Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
    Bae DG; Kim TD; Li G; Yoon WH; Chae CB
    Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HARP induces angiogenesis in vivo and in vitro: implication of N or C terminal peptides.
    Papadimitriou E; Polykratis A; Courty J; Koolwijk P; Heroult M; Katsoris P
    Biochem Biophys Res Commun; 2001 Mar; 282(1):306-13. PubMed ID: 11264008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of heparin on bovine epithelial lens cell proliferation induced by heparin affin regulatory peptide.
    Delbé J; Vacherot F; Laaroubi K; Barritault D; Courty J
    J Cell Physiol; 1995 Jul; 164(1):47-54. PubMed ID: 7790396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The angiogenic factor heparin affin regulatory peptide (HARP) induces proliferation of human peripheral blood mononuclear cells.
    Achour A; Laaroubi D; Caruelle D; Barritault D; Courty J
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL73-7. PubMed ID: 11936877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF and inhibitors of TGFbeta type-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression.
    Liu Z; Kobayashi K; van Dinther M; van Heiningen SH; Valdimarsdottir G; van Laar T; Scharpfenecker M; Löwik CW; Goumans MJ; Ten Dijke P; Pardali E
    J Cell Sci; 2009 Sep; 122(Pt 18):3294-302. PubMed ID: 19706683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
    Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
    Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.
    Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S
    Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cell proliferation induced by HARP: implication of N or C terminal peptides.
    Papadimitriou E; Heroult M; Courty J; Polykratis A; Stergiou C; Katsoris P
    Biochem Biophys Res Commun; 2000 Jul; 274(1):242-8. PubMed ID: 10903925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An engineered heparin-binding form of VEGF-E (hbVEGF-E). Biological effects in vitro and mobilizatiion of precursor cells.
    Heil M; Mitnacht-Krauss R; Issbrücker K; van den Heuvel J; Dehio C; Schaper W; Clauss M; Weich HA
    Angiogenesis; 2003; 6(3):201-11. PubMed ID: 15041796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect.
    Tan WF; Zhang XW; Li MH; Yue JM; Chen Y; Lin LP; Ding J
    Eur J Pharmacol; 2004 Sep; 499(3):219-28. PubMed ID: 15381043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-angiogenic action of plasma hyaluronan binding protein in human umbilical vein endothelial cells.
    Jeon JW; Song HS; Moon EJ; Park SY; Son MJ; Jung SY; Kim JT; Nam DH; Choi-Miura NH; Kim KW; Kim YJ
    Int J Oncol; 2006 Jul; 29(1):209-15. PubMed ID: 16773202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum response factor is a critical requirement for VEGF signaling in endothelial cells and VEGF-induced angiogenesis.
    Chai J; Jones MK; Tarnawski AS
    FASEB J; 2004 Aug; 18(11):1264-6. PubMed ID: 15180964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.